The Benefits of Polypill: Adherence and Chronotherapy [Response to Letter].
Vasc Health Risk Manag
; 19: 661-662, 2023.
Article
in En
| MEDLINE
| ID: mdl-37854581
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cardiovascular Agents
/
Cardiovascular Diseases
/
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Limits:
Humans
Language:
En
Journal:
Vasc Health Risk Manag
Journal subject:
ANGIOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: